Investinor invests in SantoSolve
Investinor has invested NOK 15 million in the Norwegian pharmaceutical company SantoSolve AS.
The company develops targeted pain therapeutics, based on a novel class of active ingredients. The company’s technology is covered by a broad range of patent applications, providing strong IPR protection. SantoSolve developes topical analgesic products based on non-radioactive strontium as the active substance.
SantoSolve was founded in 2002 and is located in Oslo.
Read more
| Fund | Investinor |
| Portfolio Company | SantoSolve |
| Date of Transaction | 2009-10-27 |
| Transaction | Acquisition |
| Seller | |
| Buyer | |
| Size of Transaction | NOK 15.0m |
| Ind. Focus | Life Science |
| Geography | Norway |
| Stage | Venture |